Some of their top picks in January included IndusInd Bank, Bank of India, Divi’s Laboratories, GlaxoSmithKline Pharmaceuticals, Aditya Birla Capital, Unichem Laboratories and Ipca Laboratories.
Nifty may hit 24,060 before recovery, IT breakout imminent: Geojit’s Anand James
Despite Friday’s recovery attempt, technical charts are painting a cautious picture for Nifty in the coming week. Anand James, Chief Market Strategist at Geojit Investments